As a secondary prophylaxis (patients experienced neutropenia in a previous cycle and were given G-CSF prophylactically in a subsequent cycle), G-CSF reduces: time for neutrophil recovery, the incidence of FN, hospitalization, and the administration of broad-spectrum antibiotics [23]. This evidence concerns the gene CSF3 and Decreased total neutrophil count.